Cargando…
Galectin‐3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients
BACKGROUND: Obesity is a precursor to heart failure with preserved ejection fraction. Biomarkers that identify preclinical metabolic heart disease (MHD) in young obese patients would help identify high‐risk individuals for heart failure prevention strategies. We assessed the predictive value of GAL3...
Autores principales: | Gopal, Deepa M., Ayalon, Nir, Wang, Yi‐Chih, Siwik, Deborah, Sverdlov, Aaron, Donohue, Courtney, Perez, Alejandro, Downing, Jill, Apovian, Caroline, Silva, Vanessa, Panagia, Marcello, Kolachalama, Vijaya, Ho, Jennifer E., Liang, Chang‐seng, Gokce, Noyan, Colucci, Wilson S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509711/ https://www.ncbi.nlm.nih.gov/pubmed/30929550 http://dx.doi.org/10.1161/JAHA.118.011100 |
Ejemplares similares
-
Relationship of Plasma Galectin-3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure
por: Gopal, Deepa M., et al.
Publicado: (2012) -
Impaired Right Ventricular Hemodynamics Indicate Preclinical Pulmonary Hypertension in Patients With Metabolic Syndrome
por: Gopal, Deepa M., et al.
Publicado: (2015) -
Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment
por: Qiu, Shangran, et al.
Publicado: (2018) -
Decreased ATP production and myocardial contractile reserve in metabolic heart disease
por: Luptak, Ivan, et al.
Publicado: (2018) -
Preclinical Alterations in Myocardial Microstructure in People with Metabolic Syndrome
por: Ho, Jennifer E., et al.
Publicado: (2017)